<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/CDEDC9AA-78F1-492E-9F1E-30F59AF1C090"><gtr:id>CDEDC9AA-78F1-492E-9F1E-30F59AF1C090</gtr:id><gtr:name>MRC Centre for Protein Engineering</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CDEDC9AA-78F1-492E-9F1E-30F59AF1C090"><gtr:id>CDEDC9AA-78F1-492E-9F1E-30F59AF1C090</gtr:id><gtr:name>MRC Centre for Protein Engineering</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/61C82DC5-11F2-4E1B-BB86-9A4F479C2095"><gtr:id>61C82DC5-11F2-4E1B-BB86-9A4F479C2095</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Bycroft</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105459896"><gtr:id>1CDB2C39-060F-46FE-8D30-8A5C0842A772</gtr:id><gtr:title>Protein Structure and Function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105459896</gtr:grantReference><gtr:abstractText>We are studying how protein levels are controlled in the body. We are looking at the factors that govern how fast proteins are made and how quickly they are disposed of. When these controls stop working correctly either too much or too little protein is made and this can lead to diseases such as cancer and genetic disorders. We are working with medical researchers to try and understand the molecular basis of these types of diseases, including polycystic kidney disease.</gtr:abstractText><gtr:technicalSummary>Cells regulate the amount of a given protein in response to many different stimuli. Two processes govern this gene expression and protein turnover. One of the main aims of this research program is to gain a detailed molecular understanding of these processes. In the field of gene expression we are focusing on two areas in particular. Firstly we are interested how posttranslational modification modulates transcription. The modification of histones plays a key role in chromatin structure and function. We are studying protein modules that recognise methylated amino acids in the tails of histones and direct the assembly of large multiprotein complexes that regulate transcription. The importance of this field is highlighted by the fact that several of the proteins involved are mutated in development disorders and cancer. Chromatin structure can also be modulated by the incorporation of variant histones. We have been studying a protein module present in macroH2A, a variant histone enriched in inactive X chromosomes. We are also studying protein modules that bind to the carboxyl-terminal domain of the largest subunit of RNA polymerase. This domain is phosphorylated during the elongation phase of transcription. This acts as a marker for the binding of proteins involved in RNA modification, enabling the coordination of transcription and RNA processing. The second area we are interested in is dsRNA. The past five years have seen dsRNA emerge as a key regulator of gene expression. We are investigating how proteins recognise dsRNA and how dsRNA binding proteins influence mRNA stability, translation and transcription. We are also examining the mechanisms that control the ubiquitin-proteasome pathway, the main system that regulates protein turnover. We are studying the assembly and function of a variety of E3 ligases, the enzymes that attach ubiquitin to proteins. One of these ligases is mutated in kidney cancers and another is encoded by the virus that causes Kaposis sarcoma. We are also studying a family of proteins that can remove ubiquitin from proteins. Finally, we are also interested in the relationship between protein quality control and the ubiquitin-proteasome system. We are also engaged in a number of programs, in collaboration with clinical research groups, in which structural and biophysical methods are used to elucidate the molecular basis of disease. We have, for example, been working on autosomal dominant polycystic kidney disease one of the most common genetic disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2261810</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Martinsried</gtr:department><gtr:description>the VHL tumor suppressor</gtr:description><gtr:id>0D29BE35-9816-493E-805E-B97386781F74</gtr:id><gtr:impact>This has produced a publication PMID: 19228690. Our collaborator is an expert in protein ubiquitination.</gtr:impact><gtr:outcomeId>Uw9Az7Yd2wS-1</gtr:outcomeId><gtr:partnerContribution>expertise in protein ubiquitination.</gtr:partnerContribution><gtr:piContribution>We have provided expertise in biological NMR spectroscopy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Haematology</gtr:department><gtr:description>Epigenetics in leukemia</gtr:description><gtr:id>A694CEB8-8A4F-4061-96C6-F1EF3A383E56</gtr:id><gtr:impact>some of this work has been published PMID: 20400950. This is a multi disciplinary project that combines our biochemical and structural biological knowledge with our colleagues expertise in mouse models of leukemia and molecular biology.</gtr:impact><gtr:outcomeId>UJt1b7Nyn25-1</gtr:outcomeId><gtr:partnerContribution>expertise in molecular biology of leukemia</gtr:partnerContribution><gtr:piContribution>we have contributed biochemical and structural biological input to a combined effort to explore the role of histone modification in the pathogenesis of leukemia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>63C62D48-05E6-49F1-B1B8-BB3E826679B5</gtr:id><gtr:title>The malignant brain tumor repeats of human SCML2 bind to peptides containing monomethylated lysine.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52473bbe8fa4089371b0708bd34feb35"><gtr:id>52473bbe8fa4089371b0708bd34feb35</gtr:id><gtr:otherNames>Santiveri CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>3E2017FFAEF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C2947D4-0674-46CE-8372-279C1CE01345</gtr:id><gtr:title>Solution structure of the C4 zinc finger domain of HDM2.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5160dbb6f1bcb254474424a7acc5532c"><gtr:id>5160dbb6f1bcb254474424a7acc5532c</gtr:id><gtr:otherNames>Yu GW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>D4FA54D06F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB193BA1-712C-45A8-BA0E-8C6C28A49C96</gtr:id><gtr:title>Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>91E19048984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25D98C52-B253-4C4C-96C9-FCD500A07D28</gtr:id><gtr:title>The structure of the FYR domain of transforming growth factor beta regulator 1.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff4c9467962ce49d0091fb734f4937f9"><gtr:id>ff4c9467962ce49d0091fb734f4937f9</gtr:id><gtr:otherNames>Garc?a-Alai MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>PgGMkLXJbUy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9436A7EF-1A1A-4FC1-AD71-CE02E4522C66</gtr:id><gtr:title>VHL mutations linked to type 2C von Hippel-Lindau disease cause extensive structural perturbations in pVHL.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/834a2208cce3312c2732ffee205d9aa5"><gtr:id>834a2208cce3312c2732ffee205d9aa5</gtr:id><gtr:otherNames>Knauth K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>auvjFwWyovc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E12E56E-DAEC-46F9-BCB7-A70E5A87A3A4</gtr:id><gtr:title>Solution structure of the BRK domains from CHD7.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>ABABB4BBDFA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE4A59F3-779E-4B88-A486-BC5F11854A3B</gtr:id><gtr:title>Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/254b59b469274ae879ceb36cdb1fa0d1"><gtr:id>254b59b469274ae879ceb36cdb1fa0d1</gtr:id><gtr:otherNames>Vezzoli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>Skak5sucCWJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C22E42E7-2A76-48E9-B7B7-C9BDCA522FD2</gtr:id><gtr:title>The PUB domain functions as a p97 binding module in human peptide N-glycanase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>4B735EB4F25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D6ED53C-8469-4CB1-840C-1815758E0983</gtr:id><gtr:title>The FtsK gamma domain directs oriented DNA translocation by interacting with KOPS.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4419be9af45a9445d615d78d62277259"><gtr:id>4419be9af45a9445d615d78d62277259</gtr:id><gtr:otherNames>Sivanathan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>9D05209EF8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7A41162-21CA-4849-BE3A-52C64A373BB5</gtr:id><gtr:title>Structural consequences of nucleophosmin mutations in acute myeloid leukemia.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4ef8b043311bbc4370efe77c4be38e7"><gtr:id>f4ef8b043311bbc4370efe77c4be38e7</gtr:id><gtr:otherNames>Grummitt CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>641393475BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>912BEFDC-665F-4DD0-8F94-91A06861E0CA</gtr:id><gtr:title>Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56d3523d2f7264b44eb37e799be70d5e"><gtr:id>56d3523d2f7264b44eb37e799be70d5e</gtr:id><gtr:otherNames>Teufel DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>EFB9A9754B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4912DD9B-771B-4FA1-9CFF-42D497EA4179</gtr:id><gtr:title>Solution structure of the FCS zinc finger domain of the human polycomb group protein L(3)mbt-like 2.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74d6a3ffbc86542d4a9b4f027be05af4"><gtr:id>74d6a3ffbc86542d4a9b4f027be05af4</gtr:id><gtr:otherNames>Lechtenberg BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>Yc5RnSRdwfZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD0E135-C0AB-4FA7-9E3B-6D950B833D4F</gtr:id><gtr:title>Functional analysis of the post-transcriptional regulator RsmA reveals a novel RNA-binding site.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7441f149c467d9cd1f8f32d69e41f9e"><gtr:id>d7441f149c467d9cd1f8f32d69e41f9e</gtr:id><gtr:otherNames>Heeb S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>B724D43BED4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D626C966-4650-4E01-95B4-1D1333D721EF</gtr:id><gtr:title>The solution structure of the ZnF UBP domain of USP33/VDU1.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61de41cef5e0acf82cff59ae4b6ce3a3"><gtr:id>61de41cef5e0acf82cff59ae4b6ce3a3</gtr:id><gtr:otherNames>Allen MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>D9E4CB01253</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105459896</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>